EU approves half-unit insulin pen from Sanofi

10/13/2013 | MedGadget.com

European regulators have granted Sanofi CE mark approval for its JuniorSTAR insulin pen, designed for use in type 1 diabetes patients 6 to 18 years of age. The reusable device supports half-unit dosing increments and works with Insuman, Lantus and Apidra, allowing more insulin dosing flexibility for health care providers.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC